EUVIMEDEUVIMED entdecken
Crossref

Distinguishing autoimmune encephalitis from its mimics using brain [¹⁸F]-FDG PET: real-world study

Hélène Rostand, Fiene Marie Kuijper, Cristina Birzu, Alberto Picca, Clémence Marois, Alice Laurenge, Antoine Rogeau, Vincent Navarro, Louis Cousyn, Vincent Davy, Alain Giron, Dimitri Psimaras und 1 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 7865-7877

DOI: 10.1007/s00259-026-08111-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 12.08.2026. Verfasst von Hélène Rostand und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Encephalitis, Positron Emission Tomography Computed Tomography, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diagnosing autoimmune encephalitis (AE) remains challenging due to heterogeneous clinical presentations, frequent seronegativity, and limited MRI sensitivity. We evaluated the diagnostic performance of brain [¹⁸F]-FDG PET/CT in a real-world cohort of patients with suspected AE. METHODS: Consecutive patients referred for [¹⁸F]-FDG PET/CT for suspected AE between January 2020 and July 2023 were retrospectively included. Final diagnoses were established using international criteria, expert consensus, and follow-up. PET findings were assessed visually, with voxel-wise and regional analyses, compared with 54 healthy controls, and stratified by age and treatment. RESULTS: Among 141 patients (48 ± 21 years), 33% had AE, 43% differential diagnoses (DD), and 24% remained undetermined. Of AE cases, 70% were definite, 63% seropositive, and 35% had supportive MRI findings. AE showed cortical hypometabolism with mesiotemporal lobe (MTL), basal ganglia, cerebellum, midbrain, and insula hypermetabolism (p < 0.05). Compared with DD, AE exhibited lower occipital/prefrontal and higher MTL, insular, and midbrain metabolism (p < 0.001), with good discrimination versus DD (AUC 0.82-0.83). MTL hypermetabolism, alone or with cortical hypometabolism, emerged as the most specific feature, whereas other regional metrics and ratios were less reliable (AUC ≤ 0.73). Accuracy of visual PET analysis was high in patients under 40 years (positive/negative predictive values 82%/81%) and declined with age to 81%/69% at 40-65 years and 79%/64% over 65 years. CONCLUSIONS: [¹⁸F]-FDG PET/CT identifies a characteristic metabolic signature of AE and differentiates it from relevant mimics, supporting its role as a complementary diagnostic biomarker, particularly in younger patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18EncephalitisPositron Emission Tomography Computed TomographyBrainHashimoto DiseaseHumansFemaleMiddle AgedDiagnosis, DifferentialMaleAdultRetrospective StudiesAged

Stichwörter der Autor:innen

Autoimmune encephalitisBrain [¹⁸F]-FDG PETNeuroinflammationSPM12

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France.
  • French Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, France MeLiS Institute -UCBL-CNRS UMR 5284 - INSERM U1314, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Hôpital…
  • Department of Neuro-oncology, Reference Centre on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis. Sorbonne Université, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, UMR S 1127, Inserm U 1127…
  • Neuro-Intensive Care Unit, Assistance Publique Hôpitaux de Paris (AP-HP), Sorbonne Université, Hôpital de la Pitié- Salpêtrière, Paris, France.
  • Laboratoire d'Imagerie Biomédicale, Sorbonne Université, INSERM, CNRS, Paris, France.
  • Department of Neurology, Epilepsy Unit, Reference Center of rare epilepsies, Pitié- Salpêtrière Hospital, and Paris Brain Institute, Assistance Publique Hôpitaux de Paris (AP-HP), Sorbonne Université, ERN-Epicare, ICM,…

Zitieren

APA

Rostand, H., Kuijper, F. M., Birzu, C., Picca, A., Marois, C., Laurenge, A., Rogeau, A., Navarro, V., Cousyn, L., Davy, V., Giron, A., Psimaras, D., & Kas, A. (2026). Distinguishing autoimmune encephalitis from its mimics using brain [¹⁸F]-FDG PET: real-world study. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 7865-7877. https://doi.org/10.1007/s00259-026-08111-x

Vancouver

Rostand H, Kuijper FM, Birzu C, Picca A, Marois C, Laurenge A, et al. Distinguishing autoimmune encephalitis from its mimics using brain [¹⁸F]-FDG PET: real-world study. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):7865-7877. doi:10.1007/s00259-026-08111-x

BibTeX
@article{Rostand2026,
  author = {Rostand, Hélène and Kuijper, Fiene Marie and Birzu, Cristina and Picca, Alberto and Marois, Clémence and Laurenge, Alice and Rogeau, Antoine and Navarro, Vincent and Cousyn, Louis and Davy, Vincent and Giron, Alain and Psimaras, Dimitri and Kas, Aurélie},
  title = {Distinguishing autoimmune encephalitis from its mimics using brain [¹⁸F]-FDG PET: real-world study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {13},
  pages = {7865--7877},
  doi = {10.1007/s00259-026-08111-x}
}
Kostenlos starten →